Innoviva (HVE) Financial Statements
Innoviva Financial Overview
Innoviva's market cap is currently $1.26B. The company's EPS TTM is $4.87; its P/E ratio is 4.32; Innoviva is estimated to report earnings on November 11, 2026, and the estimated EPS forecast is $0.42. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 425.13M | $ 358.71M | $ 310.46M | $ 331.34M | $ 391.87M |
| Gross Profit | $ 307.52M | $ 322.11M | $ 267.82M | $ 317.55M | $ 391.87M |
| Operating Income | $ 163.75M | $ 166.87M | $ 113.89M | $ 207.00M | $ 375.10M |
| EBITDA | $ 383.79M | $ 99.45M | $ 248.96M | $ 322.25M | $ 478.18M |
| Net Income | $ 271.17M | $ 23.39M | $ 179.72M | $ 213.92M | $ 265.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 550.94M | $ 412.50M | $ 193.51M | $ 291.05M | $ 201.53M |
| Total Assets | $ 1.64B | $ 1.30B | $ 1.24B | $ 1.23B | $ 926.39M |
| Total Debt | $ 269.02M | $ 451.10M | $ 449.08M | $ 544.07M | $ 394.76M |
| Net Debt | $ -281.92M | $ 146.13M | $ 255.56M | $ 253.02M | $ 193.23M |
| Total Liabilities | $ 462.32M | $ 609.90M | $ 568.55M | $ 665.71M | $ 400.46M |
| Stockholders' Equity | $ 1.17B | $ 691.16M | $ 674.96M | $ 565.79M | $ 414.74M |
| Cash Flow | |||||
| Free Cash Flow | $ 186.43M | $ 188.42M | $ 140.65M | $ 201.66M | $ 362.51M |
| Operating Cash Flow | $ 196.93M | $ 188.69M | $ 141.06M | $ 201.73M | $ 363.81M |
| Investing Cash Flow | $ 40.50M | $ -63.79M | $ -66.76M | $ -56.63M | $ 43.72M |
| Financing Cash Flow | $ 8.55M | $ -13.45M | $ -171.84M | $ -55.57M | $ -452.50M |
Currency in USD
